Probability of cumulative incidence of ESRD, disease-related death, or death from other cause for the entire cohort. Probability of cumulative incidence.

Slides:

Advertisements

Similar presentations

Date of download: 6/2/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Similar Outcomes With Hemodialysis and Peritoneal.

Advertisements

2016 Annual Data Report, Vol 2, ESRD, Ch 6

Mortality HRs for dialysis modality (PD versus HD) in 23,718 incident dialysis patients using a marginal structural model (MSM) taking into account changes.

Pneumococcal pneumonia vaccinations, by unit affiliation.

Among Medicare beneficiaries >65 years old with a index hospitalization at the time of dialysis initiation, use of post-acute SNF care was common. Among.

Positive interactions between the basic and translational research, clinical research, patient care, and training components of an academic dialysis access.

Figure 1.17 of the 2016 US Renal Data System Annual Data Report, Volume 2, chapter 1 showing the trends in the number of patients with incident ESRD (in.

The incidence of all cause graft failure, and death with a functioning graft was higher in patients who received a DCD donor transplant with total donor.

Adjusted rate ratios of hospital days and admissions for blacks and Hispanics compared with whites by age group. Adjusted rate ratios of hospital days.

End-stage renal disease in living kidney donors

Adjusted relative risk for developing end-stage renal disease (ESRD) associated with blood-pressure level BP level (mm Hg) Adjusted relative risk 95%

Cumulative incidence of (A) ESRD, (B) all-cause death, (C) all-cause death without ESRD and (D) ESRD or all-cause death in patients with T1DM diagnosed.

Survival advantage in Asian American end-stage renal disease patients1

Long-term outcomes in nondiabetic chronic kidney disease

Stephen P. McDonald Kidney International Supplements

Patient characteristics: American vs Canadian transplant patients

Baseline Characteristics by Tertiles of Homocysteine

Mortality, Hospitalization, and Technique Failure in Daily Home Hemodialysis and Matched Peritoneal Dialysis Patients: A Matched Cohort Study Eric D.

Parathyroid hormone (PTH) levels by Dialysis Outcomes and Practice Patterns Study (DOPPS) phase and selected patient characteristics. Parathyroid hormone.

Patient disposition. Patient disposition. AE, adverse event. *One patient died during the follow-up period. ^Four of the 12 discontinuations of treatment.

Three-year cumulative incidence of a gout diagnosis presented by level of kidney function and sex. Three-year cumulative incidence of a gout diagnosis.

Incidence of in-hospital mortality rates are lower in rapid correction rate group versus slow correction rate group but not significantly different by.

Lynda Anne Szczech, Ira L. Lazar Kidney International

Prehypertension: is it relevant for nephrologists?

Forest plot showing the association between center-level characteristics and death-censored technique failure after adjusting for age, sex, race, body.

Volume 76, Issue 6, Pages (September 2009)

Cumulative incidence of cardiovascular events according to medication group in participants of the 4D study with an LDL-C in its fourth quartile at baseline.

(A) Mean (SD) serum continuous erythropoietin receptor activator (C. E

Seven-year cumulative incidence of ESRD according to baseline creatinine clearance (Ccr) and result of urine test for proteinuria (19). Seven-year cumulative.

Adjusted means (±SD) of eGFR in relation to the histologic severity of nonalcoholic steatohepatitis (i.e., NASH/fibrosis stage increasing from 0 to 3)

Distribution of podocyte gene mutations in patients with genetic congenital nephrotic syndrome (CNS) and steroid–resistant nephrotic syndrome (SRNS). Distribution.

Renal replacement therapy in Latin America

Lifestyle intervention was associated with improved cardiorespiratory fitness. Lifestyle intervention was associated with improved cardiorespiratory fitness.

Intrapatient variability in cyclosporine blood levels in renal transplant patients. Intrapatient variability in cyclosporine blood levels in renal transplant.

Immunosuppression significantly reduced all-cause mortality or risk of ESRD (A) and significantly increased complete or partial remission (B) at the end.

Ionized-to-total magnesium (Mg) and calcium (Ca) ratios are lower in patients on hemodialysis than those in patients not on dialysis. Ionized-to-total.

Mean plasma concentrations of ampicillin/sulbactam in plasma of critically ill patients with AKI undergoing extended dialysis (duration depicted by box.

Ca2+ infusion rates during all three protocol versions.

Volume 88, Issue 5, Pages (November 2015)

A nationwide cohort study suggests chronic hepatitis B virus infection increases the risk of end-stage renal disease among patients in Taiwan Yi-Chun.

Risk differences for incident stroke, coronary heart disease (CHD), and cardiovascular mortality (per 1000 person-years) by clinical risk factor in the.

Response to cyclosporin A (CsA) treatment and renal outcome in patients with either nongenetic or genetic disease. Response to cyclosporin A (CsA) treatment.

Potential links between the immune dysfunction in uremia, inflammation, infection, and increased risk of atherosclerosis and cardiovascular disease. Potential.

Graph showing percentage of total patients with PTD or IGT that would be detected in each category of FBG if an oral glucose tolerance test were performed.

Distribution of vascular access type (2002–2011) among countries with stable or decreasing catheter burden over time. Distribution of vascular access type.

Stephen Pastan, J. Michael Soucie, William M. McClellan

Risk for chronic kidney disease (CKD) among Olmsted County, MN, stone formers and control subjects. Risk for chronic kidney disease (CKD) among Olmsted.

Mortality caused by cardiovascular disease (A) and sepsis (B) of patients with end-stage renal disease (ESRD) treated by dialysis compared with the general.

Cumulative mortality risk in patients with 48-h blood urea nitrogen (BUN) levels of ≥8 mg/dl or

Kaplan-Meier analysis for the cumulative percentage of patients who remained hospitalized according to presence or absence of ARF with or without other.

We identified 200 Android and 178 iOS apps using 4 search terms and narrowed this to 12 Android apps, 11 iOS apps, and 5 dual-platform apps after applying.

Comparison of Medicare reimbursement to a nephrology practice on an annual per-patient basis for care of a patient on dialysis (at two different frequencies.

Association between hyperphosphatemia (serum phosphorus ≥4

Distribution of percent consistent facility aspirin use.

Immunohistochemical and immunogluorescence analysis of renal biopsies showing significant C5b-9, C4d and C3c deposition but almost absent Bb deposition.

New dialysis starts in the United States by year in patients with and without diagnosis of diabetes. New dialysis starts in the United States by year in.

Per dialysis treatment funding and facility/network staff ratio by ESRD Network. Per dialysis treatment funding and facility/network staff ratio by ESRD.

Dialysis limitations. Dialysis limitations. (A) Recent data from observational studies and randomized, clinical trials indicate significant limitations.

Causal diagrams that represent three possible relationships between smoking, ESRD, and albumin-to-creatinine ratio (ACR) in the Study of Heart and Renal.

Renal replacement therapy using an in-line hemofilter during extracorporeal membrane oxygenation (ECMO). Renal replacement therapy using an in-line hemofilter.

Effect of intervention differed across racial and socioeconomic groups

As the patient nears the end of life (dashed arrow), there is an increasing focus on symptom control and patient goals of care and a shift in the approach.

Cumulative survival curves for deceased-donor transplant recipients who were older than 70 yr and similarly aged dialysis patients who were on the waiting.

Associations of dialysis session length with mortality and hospitalizations. Associations of dialysis session length with mortality and hospitalizations.

Risk of mortality in patients with diabetes and ESRD

Identification of thresholds for significant renal recovery in relation to patient and renal survival. Identification of thresholds for significant renal.

Mean number of dialysis sessions per patient for which intradialytic hypotension–related nursing interventions were required during the first 2 wk and.

Renal replacement therapy (RRT) using RRT machine during extracorporeal membrane oxygenation (ECMO). Renal replacement therapy (RRT) using RRT machine.

Mortality risk by age at study entry across DOPPS regions.

Distribution of facility mean treatment time, by DOPPS region and phase. Distribution of facility mean treatment time, by DOPPS region and phase. Restricted.

Presentation transcript:

Probability of cumulative incidence of ESRD, disease-related death, or death from other cause for the entire cohort. Probability of cumulative incidence of ESRD, disease-related death, or death from other cause for the entire cohort. The bold line shows the cumulative incidence of ESRD, after adjusting for competing risk, mortality from disease-related causes, and others. Patients who required dialysis at presentation and never recovered renal function were considered to be at ESRD after 3 months. Mortality from other causes represents those unrelated to ANCA disease and/or ESRD. Taewoo Lee et al. CJASN 2014;9:905-913 ©2014 by American Society of Nephrology